Oscar Health (NYSE:OSCR) Stock Breaks Above 50-Day Moving Average – Time to Sell?

Shares of Oscar Health, Inc. (NYSE:OSCR) passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $31.68 and traded as high as $32.69. Oscar Health shares last traded at $32.3830, with a volume of 4,377,805 shares.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on OSCR shares. Stephens restated an “equal weight” rating and issued a $34.00 price target on shares of Oscar Health in a research note on Thursday, September 17th. Robert W. Baird upped their price objective on shares of Oscar Health from $27.00 to $33.00 and gave the stock a “neutral” rating in a research report on Thursday, September 17th. UBS Group increased their price objective on shares of Oscar Health from $26.00 to $36.00 and gave the company a “neutral” rating in a research note on Monday, October 12th. Weiss Ratings raised shares of Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Finally, Wells Fargo & Company raised their target price on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Oscar Health presently has an average rating of “Hold” and a consensus target price of $34.90.

Oscar Health Trading Up 4.5%

The business has a fifty day simple moving average of $31.68 and a 200-day simple moving average of $23.72. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market cap of $9.99 billion, a price-to-earnings ratio of 23.13, a PEG ratio of 0.34 and a beta of 2.56.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The firm had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. During the same period last year, the company earned ($0.89) earnings per share. The business’s quarterly revenue was up 70.4% on a year-over-year basis. As a group, equities analysts forecast that Oscar Health, Inc. will post 1.83 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Adam Mcananey sold 9,092 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $285,943.40. Following the completion of the transaction, the insider owned 209,004 shares in the company, valued at $6,573,175.80. This trade represents a 4.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $32.24, for a total transaction of $806,000.00. Following the completion of the transaction, the director owned 112,121 shares of the company’s stock, valued at approximately $3,614,781.04. This trade represents a 18.23% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 874,451 shares of company stock valued at $26,761,671 over the last three months. Insiders own 22.64% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several large investors have recently modified their holdings of the business. Alps Advisors Inc. acquired a new position in Oscar Health during the 3rd quarter worth about $529,000. Kestra Private Wealth Services LLC bought a new stake in shares of Oscar Health in the 3rd quarter valued at about $245,000. XML Financial LLC acquired a new stake in shares of Oscar Health in the third quarter valued at about $303,000. Vise Technologies Inc. increased its stake in shares of Oscar Health by 25.4% in the third quarter. Vise Technologies Inc. now owns 17,067 shares of the company’s stock valued at $526,000 after buying an additional 3,461 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Oscar Health during the third quarter worth about $632,000. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.